Current Drug Development Overview: Targeting Voltage-Gated Calcium Channels for the Treatment of Pain

Author:

Antunes Flavia Tasmin Techera12ORCID,Campos Maria Martha3ORCID,Carvalho Vanice de Paula Ricardo4,da Silva Junior Claudio Antonio4,Magno Luiz Alexandre Viana5,de Souza Alessandra Hubner5,Gomez Marcus Vinicius4ORCID

Affiliation:

1. Department of Physiology and Pharmacology, University of Calgary, Calgary, AB T2N 1N4, Canada

2. Hotchkiss Brain Institute, University of Calgary, Calgary, AB T2N 1N4, Canada

3. Programa de Pós-Graduação em Odontologia, Escola de Ciências da Saúde e da Vida, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre 90619-900, RS, Brazil

4. Faculdade Santa Casa BH, Belo Horizonte 30110-005, MG, Brazil

5. Programa de Pós-Graduação em Ciências da Saúde, Faculdade Ciências Médicas de Minas Gerais (FCMMG), Belo Horizonte 30110-005, MG, Brazil

Abstract

Voltage-gated calcium channels (VGCCs) are targeted to treat pain conditions. Since the discovery of their relation to pain processing control, they are investigated to find new strategies for better pain control. This review provides an overview of naturally based and synthetic VGCC blockers, highlighting new evidence on the development of drugs focusing on the VGCC subtypes as well as mixed targets with pre-clinical and clinical analgesic effects.

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Reference200 articles.

1. Pain and the global burden of disease;Rice;Pain,2016

2. Goldberg, D.S., and McGee, S.J. (2011). Pain as a global public health priority. BMC Public Health, 11.

3. The pain crisis: What it is and what can be done;Sessle;Pain Res. Treat.,2012

4. Pain management: A fundamental human right;Brennan;Anesth. Analg.,2007

5. Evolving Pharmacotherapies for Pain: Drug Development;Nalamasu;Phys. Med. Rehabil. Clin. N. Am.,2020

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3